These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23281184)

  • 1. Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM.
    Essock-Burns E; Phillips JJ; Molinaro AM; Lupo JM; Cha S; Chang SM; Nelson SJ
    J Magn Reson Imaging; 2013 Aug; 38(2):388-400. PubMed ID: 23281184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.
    Barajas RF; Phillips JJ; Parvataneni R; Molinaro A; Essock-Burns E; Bourne G; Parsa AT; Aghi MK; McDermott MW; Berger MS; Cha S; Chang SM; Nelson SJ
    Neuro Oncol; 2012 Jul; 14(7):942-54. PubMed ID: 22711606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in dynamic susceptibility contrast MR perfusion maps generated by different methods implemented in commercial software.
    Orsingher L; Piccinini S; Crisi G
    J Comput Assist Tomogr; 2014; 38(5):647-54. PubMed ID: 24879459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
    Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
    Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Cha S; Lupo JM; Chen MH; Lamborn KR; McDermott MW; Berger MS; Nelson SJ; Dillon WP
    AJNR Am J Neuroradiol; 2007; 28(6):1078-84. PubMed ID: 17569962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange.
    Leu K; Boxerman JL; Cloughesy TF; Lai A; Nghiemphu PL; Liau LM; Pope WB; Ellingson BM
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1440-6. PubMed ID: 27079371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma multiforme versus solitary supratentorial brain metastasis: differentiation based on morphology and magnetic resonance signal characteristics.
    Maurer MH; Synowitz M; Badakshi H; Lohkamp LN; Wüstefeld J; Schäfer ML; Wiener E
    Rofo; 2013 Mar; 185(3):235-40. PubMed ID: 23196836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
    Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
    Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
    Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic assessment of multi-echo dynamic susceptibility contrast MRI using a digital reference object.
    Stokes AM; Semmineh NB; Nespodzany A; Bell LC; Quarles CC
    Magn Reson Med; 2020 Jan; 83(1):109-123. PubMed ID: 31400035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-parametric (ADC/PWI/T2-w) image fusion approach for accurate semi-automatic segmentation of tumorous regions in glioblastoma multiforme.
    Fathi Kazerooni A; Mohseni M; Rezaei S; Bakhshandehpour G; Saligheh Rad H
    MAGMA; 2015 Feb; 28(1):13-22. PubMed ID: 24691860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of contrast-enhanced SWI in patients with glioblastoma multiforme.
    Fahrendorf D; Schwindt W; Wölfer J; Jeibmann A; Kooijman H; Kugel H; Grauer O; Heindel W; Hesselmann V; Bink A
    Eur Radiol; 2013 Oct; 23(10):2868-79. PubMed ID: 23903995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors.
    Schmainda KM; Prah MA; Hu LS; Quarles CC; Semmineh N; Rand SD; Connelly JM; Anderies B; Zhou Y; Liu Y; Logan B; Stokes A; Baird G; Boxerman JL
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):626-633. PubMed ID: 30923088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
    Wong AM; Yan FX; Liu HL
    J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistency of normalized cerebral blood volume values in glioblastoma using different leakage correction algorithms on dynamic susceptibility contrast magnetic resonance imaging data without and with preload.
    Hedderich D; Kluge A; Pyka T; Zimmer C; Kirschke JS; Wiestler B; Preibisch C
    J Neuroradiol; 2019 Feb; 46(1):44-51. PubMed ID: 29753641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab.
    Leu K; Boxerman JL; Lai A; Nghiemphu PL; Pope WB; Cloughesy TF; Ellingson BM
    J Magn Reson Imaging; 2016 Nov; 44(5):1229-1237. PubMed ID: 26971534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slice accelerated gradient-echo spin-echo dynamic susceptibility contrast imaging with blipped CAIPI for increased slice coverage.
    Eichner C; Jafari-Khouzani K; Cauley S; Bhat H; Polaskova P; Andronesi OC; Rapalino O; Turner R; Wald LL; Stufflebeam S; Setsompop K
    Magn Reson Med; 2014 Sep; 72(3):770-8. PubMed ID: 24285593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
    Gahramanov S; Raslan AM; Muldoon LL; Hamilton BE; Rooney WD; Varallyay CG; Njus JM; Haluska M; Neuwelt EA
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):514-23. PubMed ID: 20395065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of 5-minute delayed transition phase imaging with 30° flip angle in gadoxetic acid-enhanced 3D gradient-echo MRI of liver, compared with 20-minute delayed hepatocyte phase MRI with standard 10° flip angle.
    Cho ES; Yu JS; Park AY; Woo S; Kim JH; Chung JJ
    AJR Am J Roentgenol; 2015 Jan; 204(1):69-75. PubMed ID: 25539239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.